Ethics statement
A randomized, double-blinded, placebo-controlled clinical trial will be undertaken. The research protocol has been reviewed and approved by the Ethics Committee of Shanghai Tongji Hospital (2020-KYSB-160, 2021-086), and it has been registered in the Chinese Clinical Trial Register (registration number ChiCTR2000037429).